Anxiety Disorders, Depression
Conditions
Brief summary
The purpose of this study is to determine whether tailored internet-administrated CBT is a feasible approach in the treatment of anxiety symptoms and comorbid anxiety and depressive symptoms in a clinical setting.
Interventions
This intervention contains 6-8 text-based self-help modules in which 4 modules are fixed (the first three and the last) and the rest are prescribed following the diagnostic telephone interview. These modules contain material on panic disorder, social phobia, stress management, assertiveness training, concentration, relaxation among other things.
Sponsors
Study design
Eligibility
Inclusion criteria
* Be between the ages of 16-25 years old * Have anxiety symptoms and/or anxiety syndrome
Exclusion criteria
* Suicide prone * Alcohol addiction * Ongoing psychological treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Beck Anxiety Inventory (BAI)- Change from baseline | Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment | Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quality of Life Inventory (QOLI)- Change from baseline | Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment | Change from baseline in quality of life statements two weeks post treatment, at six months and at 12 months post treatment. |
| Montgomery Åsberg Depression Rating Scale-Self Rated (MADRS-S)- Change from baseline | Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment | Change from baseline in depressive symptoms two weeks post treatment, at six months and at 12 months post treatment. |
| Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)- Change from baseline | Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment | Change from baseline in anxiety and depressive symptoms two weeks post treatment, at six months and at 12 months post treatment. |
Countries
Sweden